|
Nave et al, 2005
|
European Journal of Clinical Pharmacology
|
ALTANA
|
18
|
Measurements at 0, 15, 30, 45 and 60 mins
|
CIC 800 mcg (HFA MDI) od am Vs. BUD 800 mcg (turbohaler) od am
|
|
Richter et al, 2005
|
Journal of Clinical Pharmacology
|
ALTANA
|
18
|
Measurements at 0, 15, 30, 45 and 60 mins
|
CIC 800 mcg (HFA MDI) od am Vs. FP 1000 mcg (HFA MDI) od am
|
|
Lee, Fardon et al, 2005
|
Chest
|
AVENTIS
|
14
|
4 weeks Crossover with 2 week washout period
|
CIC 800 mcg (HFA MDI) bd Vs. FP 1000 mcg (HFA MDI) bd
|
|
Lee, Haggart et al, 2004
|
British Journal of Clinical Pharmacology
|
AVENTIS
|
19
|
4 weeks Crossover with 2 week washout period
|
CIC 400 mcg (HFA MDI) od am Vs. FP 250 mcg (HFA MDI) bd
|
|
Kanniess et al, 2001
|
Pulmonary Pharmacology and Therapeutics
|
None declared
|
15
|
2 weeks (Cross over study with at least 3 week washout period)
|
CIC 400 mcg (HFA MDI) od am Vs. BUD 400 mcg (turbohaler) od am
|
